Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid.
作者信息
Stewart J H, Edwards K D
出版信息
Br Med J. 1965 Nov 27;2(5473):1277-81. doi: 10.1136/bmj.2.5473.1277.
Abstract
摘要
相似文献
1
Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid.速尿与苄氟噻嗪、汞撒利和依他尼酸的临床比较。
Br Med J. 1965 Nov 27;2(5473):1277-81. doi: 10.1136/bmj.2.5473.1277.
2
Combinations of diuretics in the treatment of edema.利尿剂联合用药治疗水肿
Am Heart J. 1970 Sep;80(3):422-6. doi: 10.1016/0002-8703(70)90107-9.
3
Amiloride. A potassium-sparing natriuretic agent.氨氯吡咪。一种保钾利尿钠药。
Circulation. 1968 Jan;37(1):45-53. doi: 10.1161/01.cir.37.1.45.
4
Diuretics in edema: how they work; how to pick the best one.利尿剂治疗水肿：其作用机制；如何选择最佳利尿剂。
Med Times. 1972 Mar;100(3):86-102.
5
Diuretics. II. Clinical considerations.利尿剂。二、临床考量。
Drugs. 1971;1(2):141-65. doi: 10.2165/00003495-197101020-00003.
6
[Diuretics in refractory circulatory failure].
Wiad Lek. 1974 Jun 1;27(11):979-83.
7
[Clinical pharmacology of diuretics with special reference to furosemide and ethacrynic acid].[利尿剂的临床药理学，特别提及呋塞米和依他尼酸]
Postepy Hig Med Dosw. 1980 Jan-Feb;34(1):47-74.
8
Ethacrynic acid: assessment of saluretic and diuretic potency in patients with severe chronic renal failure.依他尼酸：重度慢性肾衰竭患者中利钠和利尿效能的评估
Med J Aust. 1967 Feb 25;1(8):375-81. doi: 10.5694/j.1326-5377.1967.tb21279.x.
9
[Mechanism of action of various natriuretics with special reference to ethacrynic acid].[各种利钠剂的作用机制，特别提及依他尼酸]
Minerva Nefrol. 1969 Jul-Aug;16(4):259-66.
10
Clinical selection of diuretic drugs in the management of cardiac edema.治疗心源性水肿时利尿剂的临床选用
Am J Cardiol. 1968 Aug;22(2):168-76. doi: 10.1016/0002-9149(68)90222-1.
引用本文的文献
1
Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions - Part I: Loop Diuretics.心力衰竭患者的利尿剂治疗：当前证据和未来方向 - 第一部分：袢利尿剂。
Curr Heart Fail Rep. 2024 Apr;21(2):101-114. doi: 10.1007/s11897-024-00643-3. Epub 2024 Jan 19.
2
Phage-Related Ribosomal Protease (Prp) of : In Vitro Michaelis-Menten Kinetics, Screening for Inhibitors, and Crystal Structure of a Covalent Inhibition Product Complex.噬菌体相关核糖体蛋白酶（Prp）的：体外米氏动力学、抑制剂筛选及共价抑制产物复合物的晶体结构。
Biochemistry. 2022 Jul 5;61(13):1323-1336. doi: 10.1021/acs.biochem.2c00010. Epub 2022 Jun 22.
3
Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction.袢利尿剂对射血分数降低的心力衰竭患者结局的影响。
Curr Heart Fail Rep. 2022 Feb;19(1):15-25. doi: 10.1007/s11897-021-00538-7. Epub 2022 Jan 17.
4
Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials.速尿和其他利尿剂治疗心力衰竭的比较效果：系统评价和随机对照试验的联合荟萃分析。
Heart Fail Rev. 2021 Jan;26(1):127-136. doi: 10.1007/s10741-020-10003-7.
5
READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure-a systematic review and network meta-analysis of randomised trials.准备：环利尿剂在慢性收缩性心力衰竭患者中的相对疗效：一项随机试验的系统评价和网络荟萃分析。
Heart Fail Rev. 2019 Jul;24(4):461-472. doi: 10.1007/s10741-019-09771-8.
6
Decongestion: Diuretics and other therapies for hospitalized heart failure.充血消除：利尿剂及其他用于住院心力衰竭患者的治疗方法。
Indian Heart J. 2016 Apr;68 Suppl 1(Suppl 1):S61-8. doi: 10.1016/j.ihj.2015.10.386. Epub 2015 Nov 24.
7
Causes and treatment of oedema in patients with heart failure.心力衰竭患者水肿的病因和治疗。
Nat Rev Cardiol. 2013 Mar;10(3):156-70. doi: 10.1038/nrcardio.2012.191. Epub 2013 Jan 15.
8
Optimal use of diuretics in patients with heart failure.
Curr Treat Options Cardiovasc Med. 2007 Aug;9(4):332-42. doi: 10.1007/s11936-007-0028-z.
9
[The effectivness of ethacrynic acid, amiloride HCl and aldadiene K in kidney insufficiency].
Klin Wochenschr. 1970 Apr 15;48(8):471-80. doi: 10.1007/BF01485097.
10
The treatment of heart failure. A methodological review of the literature.
Drugs. 1986 Dec;32(6):538-68. doi: 10.2165/00003495-198632060-00004.
本文引用的文献
1
The dosage-response curve for the comparison of mercurial diuretics.用于比较汞利尿剂的剂量-反应曲线。
Am J Med Sci. 1950 Aug;220(2):156-9. doi: 10.1097/00000441-195008000-00005.
2
[RENAL HEMODYNAMICS, WATER AND ELECTROLYTE ELIMINATION AFTER 4-CHLORO-N-(2-FURYLETHYL)-5-SULFAMOYLANTHRANILIC ACID].[4-氯-N-(2-呋喃基乙基)-5-磺胺基邻氨基苯甲酸后的肾脏血液动力学、水和电解质排泄]
Arzneimittelforschung. 1964 Jun;14:713-6.
3
[STOP-FLOW STUDIES ON THE ACTION MECHANISM OF FURSEMID].速尿作用机制的停流研究
Klin Wochenschr. 1964 Jun 15;42:569-71. doi: 10.1007/BF01487784.
4
[THE SALIDIURETIC EFFECT OF 4-CHLORO-N-(2-FURFURYLMETHYL)-5-SULFAMOYLANTHRANILIC ACID].
Arzneimittelforschung. 1964 Jan;14:44-7.
5
A CLINICAL TRIAL OF FRUSEMIDE.速尿的一项临床试验。
Lancet. 1964 Nov 21;2(7369):1088-9. doi: 10.1016/s0140-6736(64)92609-1.
6
[MODERN DIURETICS AND THEIR SIDE-EFECTS IN DIABETES MELLITUS].[现代利尿剂及其在糖尿病中的副作用]
Med Welt. 1964 Apr 18;16:922-6.
7
A NEW EFFECTIVE DIURETIC--LASIX.一种新型高效利尿剂——速尿。
Br Med J. 1964 Oct 10;2(5414):910-4. doi: 10.1136/bmj.2.5414.910.
8
[A NEW DIURETIC, FURSEMID].
Rev Med Suisse Romande. 1964 Apr;84:277-88.
9
FIVE YEARS' EXPERIENCE WITH THE EVALUATION OF DIURETIC AGENTS.利尿剂评估的五年经验
Circulation. 1963 Dec;28:1042-9. doi: 10.1161/01.cir.28.6.1042.
10
METHYLENEBUTYRYL PHENOXYACETIC ACID: NOVEL AND POTENT NATRIURETIC AND DIURETIC AGENT.亚甲基丁酰苯氧基乙酸：新型强效利钠剂和利尿剂
JAMA. 1963 Sep 14;185:854-63. doi: 10.1001/jama.1963.03060110058019.
Zotero 插件